Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS)

Stroke

Volumn 43, Issue 10, 2012, Pages 2682-2688

  Fiorella, David ^a   Derdeyn, Colin P ^b   Lynn, Michael J ^c   Barnwell, Stanley L ^d   Hoh, Brian L ^e   Levy, Elad I ^g   Harrigan, Mark R ^h   Klucznik, Richard P ^j   McDougall, Cameron G ^k   Pride, G Lee ^l   Zaidat, Osama O ^m   Lutsep, Helmi L ^d   Waters, Michael F ^f   Hourihane, J Maurice ⁿ   Alexandrov, Andrei V ⁱ   Chiu, David ^j   Clark, Joni M ^k   Johnson, Mark D ^l   Torbey, Michel T ^m   Rumboldt, Zoran ^o   Cloft, Harry J ^p   Turan, Tanya N ^o   Lane, Bethany F ^c   Janis, L Scott ^q   Chimowitz, Marc I ^o   more..

^a STONY BROOK UNIVERSITY   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EMORY UNIVERSITY   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF FLORIDA   (United States)

^g UNIVERSITY AT BUFFALO   (United States)

^h University of Alabama at Birmingham   (United States)

ⁱ The University of Alabama at Birmingham   (United States)

^j HOUSTON METHODIST HOSPITAL   (United States)

^k BARROW NEUROLOGICAL INSTITUTE   (United States)

^l UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^m MEDICAL COLLEGE OF WISCONSIN   (United States)

ⁿ DENT NEUROLOGIC INSTITUTE   (United States)

^o MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^p MAYO CLINIC   (United States)

^q NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

more..

Author keywords

angioplasty and stenting; clinical trial; intracranial stenosis

Indexed keywords

CLOPIDOGREL;

ANTICOAGULANT THERAPY; ARTICLE; BASILAR ARTERY OBSTRUCTION; BLOOD CLOTTING TIME; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; DIABETES MELLITUS; HUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RANKIN SCALE; STENT; STENTING AND AGGRESSIVE MEDICAL MANAGEMENT FOR PREVENTING RECURRENT STROKE IN INTRACRANIAL STENOSIS TRIAL; STROKE;

AGED; ANGIOPLASTY; CONSTRICTION, PATHOLOGIC; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIOPERATIVE PERIOD; RECURRENCE; RISK FACTORS; STENTS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84866730031     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.661173     Document Type: Article

References (20)

1. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365:993-1003.
2. Chimowitz MI, Lynn MJ, Turan TN, Fiorella D, Lane BF, Janis S, et al. Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial. J Stroke Cerebrovasc Dis. 2011;20:357-368.
3. Nahab F, Lynn MJ, Kasner SE, Alexander MJ, Klucznik R, Zaidat OO, et al. Risk factors associated with major cerebrovascular complications after intracranial stenting. Neurology. 2009;72:2014-2019.
4. Zaidat OO, Klucznik R, Alexander MJ, Chaloupka J, Lutsep H, Barnwell S, et al. The NIH registry on use of the Wingspan stent for symptomatic 70-99% intracranial arterial stenosis. Neurology. 2008;70:1518-1524. (Pubitemid 351589505)
5. Fiorella D, Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, et al. US multicenter experience with the Wingspan stent system for the treatment of intracranial atheromatous disease: periprocedural results. Stroke. 2007;38:881-887. (Pubitemid 46568447)
6. Smith SC Jr., Dove JT, Jacobs AK, Kennedy JW, Kereiakes D, Kern MJ, et al. ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)-executive summary. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty). J Am Coll Cardiol. 2001;37:2215-2239.
7. Barbash GI, Reiner J, White HD, Wilcox RG, Armstrong PW, Sadowski Z, et al. Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the 'smoker's paradox' from the GUSTO-1 trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol. 1995;26:1222-1229.
8. Barbash GI, White HD, Modan M, Diaz R, Hampton JR, Heikkila J, et al. Acute myocardial infarction in the young-the role of smoking. The investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. Eur Heart J. 1995;16:313-316.
9. Hasdai D, Garratt KN, Grill DE, Lerman A, Holmes DR Jr. Effect of smoking status on the long-term outcome after successful percutaneous coronary revascularization. N Engl J Med. 1997;336:755-761. (Pubitemid 27113969)
10. Hasdai D, Holmes DR Jr. Smoking and outcome after PTCA. Eur Heart J. 1997;18:1520-1522. (Pubitemid 27412403)
11. Bliden KP, Dichiara J, Lawal L, Singla A, Antonino MJ, Baker BA, et al. The association of cigarette smoking with enhanced platelet inhibition by clopidogrel. J Am Coll Cardiol. 2008;52:531-533.
12. Gurbel PA, Bliden KP, Guyer K, Cho PW, Zaman KA, Kreutz RP, et al. Platelet reactivity in patients and recurrent events post-stenting: results of the prepare post-stenting study. J Am Coll Cardiol. 2005;46:1820-1826. (Pubitemid 41579802)
13. Matetzky S, Shenkman B, Guetta V, Shechter M, Beinart R, Goldenberg I, et al. Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction. Circulation. 2004;109:3171-3175.
14. Jiang WJ, Yu W, Du B, Gao F, Cui LY. Outcome of patients with-70% symptomatic intracranial stenosis after wingspan stenting. Stroke. 2011; 42:1971-1975.
15. Yu SC, Leung TW, Lee KT, Hui JW, Wong LK. Angioplasty and stenting of atherosclerotic middle cerebral arteries with Wingspan: evaluation of clinical outcome, restenosis, and procedure outcome. AJNR Am J Neuroradiol. 2011;32: 753-758.
16. Zhang L, Huang Q, Zhang Y, Liu J, Hong B, Xu Y, Zhao W. Wingspan stents for the treatment of symptomatic atherosclerotic stenosis in small intracranial vessels: safety and efficacy evaluation. AJNR Am J Neuroradiol. 2012;33:343-347.
17. Jiang WJ, Yu W, Ma N, Du B, Lou X, Rasmussen PA. High resolution MRI guided endovascular intervention of basilar artery disease. J Neurointerv Surg. Published online ahead of print March 4, 2011.
18. Shi M, Wang S, Zhou H, Cheng Y, Feng J, Wu J. Wingspan stenting of symptomatic middle cerebral artery stenosis and perioperative evaluation using high-resolution 3 Tesla MRI. J Clin Neurosci. Published ahead of print February 14, 2012.
19. Abou-Chebl A, Steinmetz H. Critique of 'stenting versus aggressive medical therapy for intracranial arterial stenosis' by Chimowitz et al in the N Engl J Med. Stroke. 2012;43:616-620.
20. Bose A, Hartmann M, Henkes H, Liu HM, Teng MM, Szikora I, et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke. 2007;38: 1531-1537. (Pubitemid 46684170)